שווי מתואם לחוב ומזומנים SciSparc Corp (SPRC)

The investment profile of SciSparc Ltd (SPRC) is burdened by regulatory uncertainty and the volatility of early-stage neurological research trials. This chart reflects a current market value of 6.04, while SciSparc Ltd (SPRC) is recruiting top pharmacologists to discover innovative drugs. The operations of the Israeli biotech firm are based on developing autism treatments, rendering the company's growth independent of general economic trends.

The metric is calculated as the sum of market capitalization and net debt, which determines the actual cost of acquiring the business while accounting for all liabilities and liquid assets. For SciSparc Ltd (SPRC), the Enterprise Value (EV) trend reflects the balance between the investment portfolio and the risks of delays in developing treatments for Alzheimer's and Tourette's diseases, helping to identify a reversal in the fundamental trend in a timely manner.